Effects of Sibutramine Upon Steatohepatitis in Obesity and Hyperlipidemia Rats

邢象斌,严祥,张相良,祁志

DOI: https://doi.org/10.3969/j.issn.1001-1242.2004.05.016

2004-01-01

Abstract:Objective:To explore the effects of the weight-loss drug--sibutramine upon obesity and hyperlipidemia rats with steatohepatitis.Method:40 Sprague-Dawley rats fed with high-fat diet for 10 weeks were randomly divided into 2 groups. The rats in model group were fed with common diet. The rats in sibutramine group with sibutramine[2mg/(kg·d)] and common diet. Another 20 rats fed with common diet for 14 weeks acted as control group. The blood and liver tissue were collected after 4 weeks of experiment. The levels of serum aspartate transaminase (AST), alanine aminotransferase(ALT), triglycerides (TG), totalcholesterol (TC) and free fatty acids (FFA), plasma lipoprotein lipase (LPL) and hepatic lipase (HL), malondialdehyde (MDA) and tumor necrosis factor α(TNF α) in both serum and liver tissue were measured; Histopathological changes in liver were observed.Result:Compared with control group, the levels of serum lipid, AST and ALT,MDA and TNFα in both serum and liver tissue increased significantly in model group. Those of plasma LPL and HL decreased significantly; moreover,all rats in model group developed steatohepatitis.Compared with model group,the disorders of serum lipid in rats of simbutramine group were ameliorated obviously, the levels of serum ALT, serum and liver tissue MDA decreased significantly, Those of plasma LPL and HL increased markedly, the level of serum AST tended to fall. Liver histology was improved nearly to normal, but the levels of serum and liver tissue TNFα did not decrease significantly. Conclusion:Sibutramine may promote the recovery of obesity and hyperlipidemia steatohepatitis in rats by ameliorating lipid peroxidation.Author′s address Department of Gastroenterology,The First Hospital of Lanzhou Medical College,730000